UTHR UNITED THERAPEUTICS Corp

NEUTRAL Impact: 2/10 Insider Cluster (2 insiders)
Horizon immediate Filed Jun 3, 2026 Processed 11d 11h ago
Insider cluster: 2 insiders, $1.4M total
Latest settled — T+1d ⚠ clustered
UTHR ▼ -0.16% at T+1d
NEUTRAL call ✗ call lost -0.16% · α vs SPY +2.44% · entry $547.22 → $546.37
Next anchor: T+5d due 5d ago
Last close $545.96 (close Jun 12) · -0.23% from $547.22 entry
Entry anchored
Jun 3, 2026
via day open
T+1d
-0.16%
call -0.16% · α +2.44%
$546.37
settled 11d ago
T+5d
call — · α —
due 5d ago
T+20d
call — · α —
in 17d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

CEO Martine Rothblatt and CFO James Edgemond sold a combined ~$1.41M in UTHR shares over five trading days, entirely from exercised options. These are routine same-day stock-for-tax sales (cashless exercises) — not open-market liquidation of unrestricted shares. At 0.006% of UTHR's $22.9B market cap, the dollar value is trivial and carries no informational signal. Multiple past neutral-scored UTHR reports have negative T+20 alpha (historical win rate 17%), consistent with the model underperforming on this name. The cross-filing actuarial verdicts show near-uniform amplification for this combo type, but the standalone economics of these sales are too small to warrant an impact override.

Key Financial Metrics

Direction
selling
Insiders
2

Actionable Insight

Insider sales are routine option-exercise tax-withholding transactions. Do not read bearish signal. Monitor upcoming quarterly earnings (likely August 2026) for pipeline progress on Tyvaso and any clinical data readouts — those are the material catalysts for UTHR, not this cluster.

Key Facts

  • CEO Martine Rothblatt sold 2,820 shares total at ~$535-562 over 3 trading days, all from option exercises at exercises at $0 and $146.03 per share.
  • CFO James Edgemond sold 3,200 shares total at ~$545-561 over 2 trading days, all from option exercises at exercises at $0 and $117.76 per share.
  • Total open-market sale proceeds: ~$2.5M (includes proceeds from shares sold same-day as option exercise). Net cash received by insiders after strike costs: ~$1.41M.
  • All sales are same-day sale-to-cover transactions from option exercise — routine tax-withholding pattern, not discretionary portfolio liquidation.
  • Total sale value is 0.006% of UTHR's $22.9B market cap — economically trivial.
  • Historical UTHR reports show a T+20 win rate of 17% and average negative alpha of -6.51%, suggesting prior scoring patterns have underperformed on this name.
  • The SCORE CALIBRATION block does not apply (scores 2-4 neutral filings have no conditional-p metric in this segment).

Financial Impact

Total open-market sales proceeds of ~$1.41M (net of strike costs) — 0.006% of market cap. Trivial.

Risk Factors

  • The historical T+20 alpha for UTHR neutral-rated reports is -6.51% — this stock has underperformed model expectations systematically, but the signal has been from event timing and forward guidance, not insider sales.
  • CEO Rothblatt sold shares at an average of ~$545, near 52-week highs — but the pattern is consistent with her regular option-exercise cadence.
  • No open-market purchases alongside these sales to offset selling signal.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
77% bullish (22 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1780518915452
51 reports for UTHR
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
Type Now
Jun 10, 2026
4d ago
Insider Cluster
NEUTRAL ★ 2/10
$544.59 awaiting T+1awaiting T+1$545.96 (+0.25%)
Jun 9, 2026
5d ago
Insider Cluster
NEUTRAL ★ 2/10
$553.04 awaiting T+1awaiting T+1$545.96 (−1.28%)
Jun 5, 2026
9d ago
Insider Cluster
NEUTRAL ★ 2/10
$547.10 awaiting T+1awaiting T+1$545.96 (−0.21%)
Jun 4, 2026
10d ago
Insider Cluster
NEUTRAL ★ 3/10
$547.10 awaiting T+1awaiting T+1$545.96 (−0.21%)
Jun 4, 2026
10d ago
Insider Cluster
NEUTRAL ★ 2/10
$547.10 awaiting T+1awaiting T+1$545.96 (−0.21%)
Jun 3, 2026
11d ago
Insider Cluster
NEUTRAL ★ 2/10
$547.22 $546.37▼ −0.16%▲ +2.44%$545.96 (−0.23%)
May 29, 2026
16d ago
Insider Cluster
NEUTRAL ★ 2/10
$544.45 $539.91▼ −0.83%▼ −0.98%$545.96 (+0.28%)
May 28, 2026
17d ago
Insider Cluster
NEUTRAL ★ 3/10
$553.34 $544.45▼ −1.61%▼ −1.86%$545.96 (−1.33%)
May 27, 2026
18d ago
Insider Cluster
NEUTRAL ★ 2/10
$561.70 $553.34▼ −1.49%▼ −1.73%$545.96 (−2.80%)
May 26, 2026
19d ago
Insider Cluster
NEUTRAL ★ 3/10
$567.74 $561.70▼ −1.06%▼ −1.62%$545.96 (−3.84%)
Showing 10 of 51

US Market Status

Market Closed — Opens in 5h

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access